MX:IPNN Stock Latest News
Company AnnouncementsIpsen Raises 2026 Guidance as Late‑Stage Pipeline and Acquisitions Drive Growth1w ago
Company AnnouncementsIpsen Reports September 2026 Share Capital and Voting Rights3w ago
Company AnnouncementsIpsen reports €147 average price in latest share buyback transactions1M ago
Company AnnouncementsIpsen Repurchases 25,000 Shares Under Ongoing Buyback Programme1M ago- Company AnnouncementsIpsen Adds Veteran Life Sciences Executive Mariette Finet to Its Board1M ago
Company AnnouncementsIpsen Reports Share Buybacks for Late August and Early September 20261M ago
Company AnnouncementsIpsen Updates Market on Share Capital and Voting Rights for August 20262M ago
Company AnnouncementsIpsen Reports Modest Share Buybacks in Late August 20262M ago- Company AnnouncementsIpsen Reports No Share Buybacks in Week of 17–21 August 20262M ago
Company AnnouncementsIpsen boosts hematology pipeline with Kartos Therapeutics acquisition2M ago
Company AnnouncementsIpsen updates investors on July 2026 share capital and voting rights2M ago- Company AnnouncementsIpsen Reports Share Buybacks on Euronext Paris in Late July 20263M ago
- Company AnnouncementsIpsen lifts 2026 guidance on strong H1 results and pipeline-boosting deals3M ago
- Company AnnouncementsIpsen Strengthens Board with Appointment of Governance Expert Catherine Bradley3M ago
Company AnnouncementsIpsen Reports Share Buybacks Totaling 13,930 Shares Over Late July3M agoCompany AnnouncementsIpsen’s Bylvay misses Phase III goal in biliary atresia, limiting expansion bid3M ago